-
1
-
-
84962531279
-
Global Tuberculosis Report 2016
-
Geneva: World Health Organization
-
WHO. Global Tuberculosis Report 2016. Geneva: World Health Organization; 2016.
-
(2016)
-
-
-
2
-
-
84987710871
-
WHO treatment guidelines for drug-resistant tuberculosis
-
2016 Update (WHO/HTM/TB/2016.04). Geneva: World Health Organization
-
WHO. WHO treatment guidelines for drug-resistant tuberculosis. 2016 Update (WHO/HTM/TB/2016.04). Geneva: World Health Organization; 2016.
-
(2016)
-
-
-
3
-
-
60749083864
-
Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis
-
Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, Gandhi NR, Galvani AP. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis. 2009;9:153-61.
-
(2009)
Lancet Infect Dis
, vol.9
, pp. 153-161
-
-
Orenstein, E.W.1
Basu, S.2
Shah, N.S.3
Andrews, J.R.4
Friedland, G.H.5
Moll, A.P.6
Gandhi, N.R.7
Galvani, A.P.8
-
4
-
-
24944456673
-
Levofloxacin treatment of active tuberculosis and the risk of adverse events
-
Marra F, Marra CA, Moadebi S, Shi P, Elwood RK, Stark G, FitzGerald JM. Levofloxacin treatment of active tuberculosis and the risk of adverse events. Chest. 2005;128:1406-13.
-
(2005)
Chest
, vol.128
, pp. 1406-1413
-
-
Marra, F.1
Marra, C.A.2
Moadebi, S.3
Shi, P.4
Elwood, R.K.5
Stark, G.6
FitzGerald, J.M.7
-
5
-
-
0038788963
-
Fluoroquinolones, tuberculosis, and resistance
-
Ginsburg AS, Grosset JH, Bishai WR. Fluoroquinolones, tuberculosis, and resistance. Lancet Infect Dis. 2003;3:432-42.
-
(2003)
Lancet Infect Dis
, vol.3
, pp. 432-442
-
-
Ginsburg, A.S.1
Grosset, J.H.2
Bishai, W.R.3
-
6
-
-
1942476132
-
Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings
-
Noel GJ, Goodman DB, Chien S, Solanki B, Padmanabhan M, Natarajan J. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings. J Clin Pharmacol. 2004;44:464-73.
-
(2004)
J Clin Pharmacol
, vol.44
, pp. 464-473
-
-
Noel, G.J.1
Goodman, D.B.2
Chien, S.3
Solanki, B.4
Padmanabhan, M.5
Natarajan, J.6
-
7
-
-
84907377122
-
Multidrug-resistant tuberculosis and culture conversion with bedaquiline
-
Diacon AH, Pym A, Grobusch MP, de Los Rios JM, Gotuzzo E, Vasilyeva I, Leimane V, Andries K, Bakare N, De Marez T, Haxaire-Theeuwes M, Lounis N, Meyvisch P, De Paepe E, van Heeswijk RPG, Dannemann B. Multidrug-resistant tuberculosis and culture conversion with bedaquiline. N Engl J Med. 2014;371:723-32.
-
(2014)
N Engl J Med
, vol.371
, pp. 723-732
-
-
Diacon, A.H.1
Pym, A.2
Grobusch, M.P.3
Los Rios, J.M.4
Gotuzzo, E.5
Vasilyeva, I.6
Leimane, V.7
Andries, K.8
Bakare, N.9
Marez, T.10
Haxaire-Theeuwes, M.11
Lounis, N.12
Meyvisch, P.13
Paepe, E.14
Heeswijk, R.P.G.15
Dannemann, B.16
-
8
-
-
84861864703
-
Delamanid for multidrug-resistant pulmonary tuberculosis
-
Gler MT, Skripconoka V, Sanchez-Garavito E, Xiao H, Cabrera-Rivero JL, Vargas-Vasquez DE, Gao M, Awad M, Park S-K, Shim TS, Suh GY, Danilovits M, Ogata H, Kurve A, Chang J, Suzuki K, Tupasi T, Koh W-J, Seaworth B, Geiter LJ, Wells CD. Delamanid for multidrug-resistant pulmonary tuberculosis. N Engl J Med. 2012;366:2151-60.
-
(2012)
N Engl J Med
, vol.366
, pp. 2151-2160
-
-
Gler, M.T.1
Skripconoka, V.2
Sanchez-Garavito, E.3
Xiao, H.4
Cabrera-Rivero, J.L.5
Vargas-Vasquez, D.E.6
Gao, M.7
Awad, M.8
Park, S.-K.9
Shim, T.S.10
Suh, G.Y.11
Danilovits, M.12
Ogata, H.13
Kurve, A.14
Chang, J.15
Suzuki, K.16
Tupasi, T.17
Koh, W.-J.18
Seaworth, B.19
Geiter, L.J.20
Wells, C.D.21
more..
-
9
-
-
84963730907
-
Global tuberculosis report
-
20th Edition. Geneva: World Health Organization
-
WHO. Global tuberculosis report. 20th Edition. Geneva: World Health Organization; 2015.
-
(2015)
-
-
-
10
-
-
0034525584
-
Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects
-
Démolis JL, Kubitza D, Tennezé L, Funck-Brentano C. Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects. Clin Pharmacol Ther. 2000;68:658-66.
-
(2000)
Clin Pharmacol Ther
, vol.68
, pp. 658-666
-
-
Démolis, J.L.1
Kubitza, D.2
Tennezé, L.3
Funck-Brentano, C.4
-
11
-
-
84869026328
-
Fluoroquinolones and the risk of serious arrhythmia: a population-based study
-
Lapi F, Wilchesky M, Kezouh A, Benisty JI, Ernst P, Suissa S. Fluoroquinolones and the risk of serious arrhythmia: a population-based study. Clin Infect Dis. 2012;55:1457-65.
-
(2012)
Clin Infect Dis
, vol.55
, pp. 1457-1465
-
-
Lapi, F.1
Wilchesky, M.2
Kezouh, A.3
Benisty, J.I.4
Ernst, P.5
Suissa, S.6
-
12
-
-
77951782678
-
Rip Van Winkle wakes up: development of tuberculosis treatment in the 21st century
-
Burman WJ. Rip Van Winkle wakes up: development of tuberculosis treatment in the 21st century. Clin Infect Dis. 2010;50 Suppl 3:S165-72.
-
(2010)
Clin Infect Dis
, vol.50
, pp. S165-S172
-
-
Burman, W.J.1
-
13
-
-
34447126309
-
Pharmacokinetics and pharmacodynamics of antimicrobials
-
Drusano GL. Pharmacokinetics and pharmacodynamics of antimicrobials. Clin Infect Dis. 2007;45 Suppl 1:S89-95.
-
(2007)
Clin Infect Dis
, vol.45
, pp. S89-95
-
-
Drusano, G.L.1
-
14
-
-
40549084636
-
Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis
-
Peloquin CA, Hadad DJ, Molino LPD, Palaci M, Boom WH, Dietze R, Johnson JL. Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis. Antimicrob Agents Chemother. 2008;52:852-7.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 852-857
-
-
Peloquin, C.A.1
Hadad, D.J.2
Molino, L.P.D.3
Palaci, M.4
Boom, W.H.5
Dietze, R.6
Johnson, J.L.7
-
15
-
-
84878560475
-
Global tuberculosis report 2013
-
Geneva: World Health Organization
-
WHO. Global tuberculosis report 2013. Geneva: World Health Organization; 2013.
-
(2013)
-
-
-
16
-
-
33646463191
-
Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome
-
Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, Skripconoka V, Wells CD, Leimane V. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome. Ann Intern Med. 2006;144:650-9.
-
(2006)
Ann Intern Med
, vol.144
, pp. 650-659
-
-
Holtz, T.H.1
Sternberg, M.2
Kammerer, S.3
Laserson, K.F.4
Riekstina, V.5
Zarovska, E.6
Skripconoka, V.7
Wells, C.D.8
Leimane, V.9
-
17
-
-
0032581454
-
A simple method of sample size calculation for linear and logistic regression
-
Hsieh FY, Bloch D a, Larsen MD. A simple method of sample size calculation for linear and logistic regression. Stat Med. 1998;17:1623-34.
-
(1998)
Stat Med
, vol.17
, pp. 1623-1634
-
-
Hsieh, F.Y.1
Bloch, D.2
Larsen, M.D.3
|